Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in ...

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in breast cancer patients can interact and drive resistance to certain drugs ...

In a groundbreaking study published in BME Frontiers , researchers from the University of California, Los Angeles (UCLA), in ...

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...

Although the Graves disease treatment landscape remains challenging, emerging therapies could shift existing treatment ...

Researchers have identified a potential treatment strategy for Rett syndrome via alternative splicing modulation of the MECP2 gene.

The FDA approved this combination tablet in the same population late last year based on the AMPLITUDE study data.